Publications


Click logo for all publications

Selected Papers:

  1. Liu, Y, Sethi, NS, Hinoue T, Schneider BG, Cherniack, AD, Sanchez-Vega F, Seoanoe JA, Farshidfar F, Bowlby R, Islam M, Kim J, Chatila W, Akbani R, Kanchi RS, Rabkin CS, Willis JE, Wang KK, McCall SJ, Mishra L, Ojesina AI, Bullman S, Pedamallu CS, Lazar AJ, Sakai R, The Cancer Genome Atlas Netowrk, Thorsson V, Bass AJ*, Laird PW. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell, in press.
  2. Pectasides, E., Stachler, M. D., Derks, S., Liu, Y., Maron, S., Islam, M., Alpert, L., Kwak, H., Kindler, H., Polite, B., Sharma, M. R., Allen, K., O’Day, E., Lomnicki, S., Maranto, M., Kanteti, R., Fitzpatrick, C., Weber, C., Setia, N., Xiao, S. Y., Hart, J., Nagy, R., Kim, K. M., Choi, M. G., Min, B. H., Nason, K. S., O’Keefe, L., Watanabe, M., Baba, H., Lanman, R., Agoston, A. T., Oh, D. J., Dunford, A., Thorner, A. R., Ducar, M. D., Wollison, B. M., Coleman, H. A., Ji, Y., Posner, M. C., Roggin, K. K., Turaga, K., Chang, P., Hogarth, K., Siddiqui, U., Gelrud, A., Ha, G., Freeman, S. S., Rhoades, J., Reed, S., Gydush, G., Rotem, D., Davison, J., Imamura, Y., Adalsteinsson, V., Lee, J., Bass, A. J. and Catenacci, D. V. Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma. Cancer Discovery. 2018
  3. Zhou J, Wu Z, Wong G, Pectasides E, Nagaraja A, Stachler M, Zhang H, Chen T, Zhang H, Liu JB, Xu X, Sicinska E, Sanchez-Vega F, Rustgi AK, Diehl JA, Wong KK, Bass AJ. CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma. Nature communications. 2017
  4. Cancer Genome Atlas Research Network*. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017;541(7636):169-75.
  5. Stachler M, Taylor-Weiner A, Peng S, McKenna A, Agoston A, Odze RD, Davison JM, Nason KS, Loda M, Leschiner I, Stewart, S, Stojanov C, Seepo S, Lawrence MS, Ferrer Torres D, Lin J, Chang AC, Gabriel SB, Lander ES, Beer DG, Getz G, Carter SL, Bass AJ. Paired genomic sequencing of Barrett’s Esophagus and Esophageal Adenocarcinoma. Nature Genetics, 2015 Sep;47(9):1047-55
  6. Kim J, Fox C, Peng S, Pusung M, Pectasides E, Mathee E, Hong YS, Do I, Jang J, Thorner AR, Van Hummelen P, Rustgi AK, Wong K, Zhou Z, Tang P, Kim KM, Lee J, Bass AJ. Pre-existing alterations impact Trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinoma. Journal of Clinical Investigation, 2014 Dec 1;124(12):5145-58.
  7. TCGA Consortium. Comprehensive Molecular Characterization of Gastric Adenocarcinoma. Nature, 2014 Sep 11;513(7517):202-9
  8. Watanabe H, Ma Q, Peng S, Adelmant G, Swain D, Song W, Fox C, Francis, JM, Pedamallu CS, DeLuca DS, Brooks AN, Wang S, Que J., Rustgi AK, Wong KK, Ligon KL, Liu, XS, Marto JA, Meyerson M, Bass AJ. SOX2-p63 interaction and genomic localization in squamous cell carcinoma. Journal of Clinical Investigation, 2014 Apr 1;124(4):1636-45.
  9. Dulak AM, Stojanov P, Peng, S, Lawrence MS, Fox C, Stewart, C, Bandla S, Imamura Y, Schumacher SE, Shefler E, Mckenna A, Cibulskis K, Sivachenko A, Carter SL, Saksena G, Voet D, Ramos AH, Auclari D, Thompason K, Sougne C, Onofrio RC, Guiducci C, Beroukhim R, Zhou D, Lin L, Reddy R, Chang R, Landrenau R, Luketich JD, Pennathur A, Ogino S, Golub TR, Gabriel SB, Lander ES, Beer DG, Godfrey TG, Getz G, Bass AJ. Exome and whole genome sequencing of esophageal adenocarcinoma identified recurrent driver events and mutational complexity. Nature Genetics. 2013. 45(5):478-86.
Top